Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Up 225.0% in November

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) saw a large growth in short interest in November. As of November 30th, there was short interest totalling 52,000 shares, a growth of 225.0% from the November 15th total of 16,000 shares. Based on an average daily volume of 273,600 shares, the short-interest ratio is currently 0.2 days.

Biodexa Pharmaceuticals Stock Performance

Shares of BDRX remained flat at $4.45 during trading hours on Thursday. The stock had a trading volume of 18,460 shares, compared to its average volume of 149,485. Biodexa Pharmaceuticals has a 1 year low of $3.50 and a 1 year high of $81.03. The company has a 50-day moving average of $5.40.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.